Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Autolus Therapeutics (AUTL) Intangibles: 2021-2024

Historic Intangibles for Autolus Therapeutics (AUTL) over the last 2 years, with Dec 2024 value amounting to $12.4 million.

  • Autolus Therapeutics' Intangibles was N/A to $20.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.3 million, marking a year-over-year change of. This contributed to the annual value of $12.4 million for FY2024, which is N/A change from last year.
  • As of FY2024, Autolus Therapeutics' Intangibles stood at $12.4 million, which was up 18,935.38% from $65,000 recorded in FY2021.
  • Over the past 5 years, Autolus Therapeutics' Intangibles peaked at $12.4 million during FY2024, and registered a low of $65,000 during FY2021.
  • Moreover, its 1-year median value for Intangibles was $12.4 million (2024), whereas its average is $12.4 million.